Analysis of Immune Responses in Mice Orally Immunized with Recombinant pMG36e-SP-TSOL18/ and pMG36e-TSOL18/ Vaccines of .

Authors:
Bi Ying Zhou
Bi Ying Zhou
School of Basic Medical Sciences
Jun Chao Sun
Jun Chao Sun
School of Basic Medical Sciences
Xiang Li
Xiang Li
Huazhong University of Science and Technology
Yue Zhang
Yue Zhang
Institute of Hematology and Blood Diseases Hospital
China
Bo Luo
Bo Luo
Huazhong University of Science and Technology
China
Nan Jiang
Nan Jiang
Nanfang Hospital
Guangzhou Shi | China
Mei Chen Liu
Mei Chen Liu
Graduate Institute of Environmental Engineering
Atlanta | United States

J Immunol Res 2018 18;2018:9262631. Epub 2018 Nov 18.

Department of Parasitology, School of Basic Medical Sciences, Zunyi Medical University, Zunyi, China.

Cysticercosis is a cosmopolitan zoonotic parasitic disease infected by larval of (). Several drugs for the treatment of cysticercosis, such as praziquantel, albendazole, and mebendazole, have certain toxicity and side effects. Considering that there is no vaccine available, we studied a new vaccine for cysticercosis in this study. The complete gene and the optimized gene fragments were obtained using PCR-based accurate synthesis method. The secretory and intracellular recombinant pMG36e-SP-TSOL18/ () and pMG36e-TSOL18/ vaccines of were prepared. Immune responses in mice orally immunized with these two recombinant vaccines were analyzed by the determination of specific antibodies (IgG, IgG1, IgG2a, and sIgA) in serum, spleen lymphocyte proliferation, and cytokines (IL-2, IFN-, IL-4, and IL-10) in spleen lymphocyte culture supernatant. Our results showed that, after the first immunization, in these two recombinant vaccine groups, the levels of serum specific IgG, IgG2a, and IgG1 increased on 14-56 d and reached the highest level on days 42, 42, and 28, respectively. The level of specific sIgA of intestinal mucosa also increased on 14-56 d and reached the highest level on day 42. The level of spleen lymphocyte proliferation increased on 14-56 d and reached the highest level on day 42. The levels of IL-2, IFN-, IL-4, and IL-10 in spleen lymphocyte culture supernatant increased on 14-56 d and reached the highest level on days 42, 42, 28, and 28, respectively. These results indicated that the recombinant pMG36e-SP-TSOL18/ and pMG36e-TSOL18/ vaccines can induce specific cellular, humoral, and mucosal immune responses in mice with oral vaccination. More importantly, the recombinant pMG36e-SP-TSOL18/ vaccine has a better immune effect. In summary, these results demonstrated the possibility of using strain as a vector to deliver protective antigens of .

Download full-text PDF

Source
http://dx.doi.org/10.1155/2018/9262631DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276433PMC
February 2019
18 Reads

Publication Analysis

Top Keywords

14-56 d reached
16
reached highest
16
highest level
16
spleen lymphocyte
16
recombinant pmg36e-sp-tsol18/
16
increased 14-56 d
16
pmg36e-sp-tsol18/ pmg36e-tsol18/
12
immune responses
12
responses mice
12
pmg36e-tsol18/ vaccines
12
lymphocyte culture
8
culture supernatant
8
ifn- il-4
8
level days
8
lymphocyte proliferation
8
il-2 ifn-
8
level day
8
il-4 il-10
8
il-10 spleen
8
mice orally
8

References

(Supplied by CrossRef)
Article in China Tropical Medicine
China Tropical Medicine 2010

Similar Publications